CVS Feels Wal-Mart Cut

 

Wal-Mart (WMT) plunged the pharmacy sector into a debilitating price war Thursday.

Shares of CVS (CVS) and other drug store chains tanked.

The selloff started after Wal-Mart said it will sell a month's worth of generic drugs for $4.

The Bentonville, Ark., retail giant said the move covers nearly 300 generic drugs in the Tampa Bay, Fla., area. Wal-Mart plans to expand the offering to the entire state in January and the rest of the country later.

"Each day in our pharmacies we see customers struggle with the cost of prescription drugs," said CEO H. Lee Scott Jr. "By cutting the cost of many generics to $4, we are helping to ensure that our customers and associates get the medicines they need at a price they can afford. That's a real solution for our nation's working families."

Wal-Mart said its pricing plan represents a substantial discount to list prices on covered generic drugs.

Wall Street read that as a notice to flee the pharmacy aisle. CVS plunged 9%, Walgreen (WAG) dropped 6% and Rite Aid (RAD) lost 5%.

The trading was furious and the selloff steep. CVS lost nearly $3 billion in market value in trading that amounted by 11:30 a.m. EDT to quadruple its daily average volume.

Among pharmacy benefit managers, which mail discounted drugs in bulk to customers, Medco (MHS), Caremark (CMX) and Express Scripts (ESRX) each sank at least 3% Thursday.

Wal-Mart dropped 41 cents to $48.46.

>To order reprints of this article, click here: Reprints

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,890.46 1,351.95 2,927.23 20.47
Oil *
118.75
UP
6.51
UP
1.99
UP
11.37
UP
0.72
10 Yr
2.05%
SPDR Gold
168.02
+0.05%
+0.15%
+0.39%
+3.65%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet